Reuters logo
BRIEF-DBV Technologies ‍announces positive data from Phase IIb trial and long-term study of Viaskin Peanut​
November 14, 2017 / 4:41 PM / 6 days ago

BRIEF-DBV Technologies ‍announces positive data from Phase IIb trial and long-term study of Viaskin Peanut​

Nov 14 (Reuters) - DBV TECHNOLOGIES SA:

* ‍ANNOUNCES PUBLICATION OF POSITIVE DATA FROM PHASE IIB TRIAL AND LONG-TERM STUDY OF VIASKIN PEANUT​

* ‍PRIMARY ENDPOINT OF PHASE IIB STUDY WAS MET AFTER 12 MONTHS OF TREATMENT​

* ‍LONG-TERM EXTENSION DATA SHOWED TREATMENT BENEFIT INCREASES OVER TIME​

* ‍ONGOING VIASKIN PEANUT PHASE III PROGRAM INCLUDES THREE GLOBAL STUDIES IN CHILDREN​ Source text for Eikon: Further company coverage: (Gdynia Newsroom)

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below